Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Core Scientific (CORZ) Operating Expenses (2020 - 2026)

Core Scientific has reported Operating Expenses over the past 7 years, most recently at $44.8 million for Q1 2026.

  • Quarterly results put Operating Expenses at $44.8 million for Q1 2026, up 38.9% from a year ago — trailing twelve months through Mar 2026 was $159.5 million (up 14.69% YoY), and the annual figure for FY2025 was $159.2 million, up 26.85%.
  • Operating Expenses reached $44.8 million in Q1 2026 per CORZ's latest filing, up from -$11.6 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $105.6 million in Q2 2022 and bottomed at -$11.6 million in Q4 2025.
  • Median Operating Expenses over the past 5 years was $40.3 million (2023), compared with a mean of $39.7 million.
  • The largest annual shift saw Operating Expenses soared 1179.17% in 2022 before it crashed 138.69% in 2025.
  • Over 5 years, Operating Expenses stood at $41.6 million in 2022, then decreased by 2.99% to $40.3 million in 2023, then fell by 25.46% to $30.1 million in 2024, then tumbled by 138.69% to -$11.6 million in 2025, then skyrocketed by 485.71% to $44.8 million in 2026.
  • Business Quant data shows Operating Expenses for CORZ at $44.8 million in Q1 2026, -$11.6 million in Q4 2025, and $69.4 million in Q3 2025.